News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
The value of the ESMO Sarcoma and Rare Cancers Congress 2025 for advancing oncology research
ESMO/LinkedIn
Feb 7, 2025, 18:47

The value of the ESMO Sarcoma and Rare Cancers Congress 2025 for advancing oncology research

ESMO (European Society for Medical Oncology) shared a post on LinkedIn:

“Dr. Pawel Sobczuk and Dr. Christopher Oing highlight the value of the ESMO Sarcoma and Rare Cancers Congress 2025 (20–22 March, Lugano, Switzerland) for advancing oncology research and career development.

Late registration available until 19 February – secure your place today!”

More posts featuring ESMO.

cancer Christopher Oing ESMO ESMO Rare Cancers 2025 ESMO Sarcoma and Rare Cancers Congress 2025 European Society for Medical Oncology OncoDaily Oncology Pawel Sobczuk
Special Coverage
Voices
Aug 25, 2025, 11:07
Miriam Mutebi: From Lab Bench to Bedside
Opinion
Aug 25, 2025, 10:40
Udhayvir Grewal Thanks Jen Riechek for Her Leadership in ASCO EO/AYA Community of Practice
Science
Aug 25, 2025, 09:45
Myeloma Paper of the Day, August 25th, Suggested by Robert Orlowski
Voices
Aug 25, 2025, 09:35
Abdu Adem Yesufe: SPHMMC LINAC Installation Is Complete - A Milestone for Patient Care
Techology
Aug 25, 2025, 09:21
Olivier Elemento: A New Paradigm for Data Interaction - Combining Voice and Augmented Reality
Voices
Aug 25, 2025, 09:09
Caryn Lerman: USC Norris Showcases Future Leaders in Cancer Research
Positive
Aug 25, 2025, 09:01
Joanna Metzner-Sadurski: Historic 50 Million Dollar Anonymous Gift to the Medical University of South Carolina
Voices
Aug 25, 2025, 08:49
Narjust Florez: Boston City Councilor Explores the EQUAL Lung Cancer Screening Study
Voices
Aug 25, 2025, 08:46
Vivek Subbiah: Health-Related Quality of Life in KRASG12C-Mutated Colorectal Cancer
Dialogues
Aug 25, 2025, 06:21
Balstilimab and Botensilimab insights with Dr Benjamin Shelchter - Latest MSS CRC Data from ESMO GI
Voices
Aug 24, 2025, 21:47
Pat Garcia-Gonzalez: One Year of Breast Cancer Program Success in Kenya
Voices
Aug 24, 2025, 21:22
Gustavo Viani: Time to Rethink Brain Metastasis Management